3:01 PM
 | 
Jun 19, 2018
 |  BC Extra  |  Financial News

Decibel raises $55M in series C, names Scangos chairman

Decibel Therapeutics Inc. (Boston, Mass.) raised $55 million in a series C round from existing investors Third Rock Venture, GV, SR One and Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) and new investors Foresite Capital, Bessemer Venture Partners, Schroder Adveq, S-Cubed and Longevity. Other new undisclosed institutional investors...

Read the full 205 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >